Association Between Influenza Vaccination and SARS-CoV-2 Infection

被引:0
|
作者
Ma'ayeh, Marwan [1 ]
de Voest, Jessica A. [2 ]
Hughes, Brenna L. [3 ]
Grobman, William A. [4 ]
Saade, George R. [5 ]
Manuck, Tracy A. [3 ]
Longo, Monica [6 ]
Simhan, Hyagriv N. [7 ]
Rouse, Dwight J. [8 ]
Mendez-Figueroa, Hector [9 ]
Gyamfi-Bannerman, Cynthia [10 ]
Bailit, Jennifer L. [11 ]
Costantine, Maged M. [1 ]
Sehdev, Harish M. [12 ]
Tita, Alan T. N. [13 ]
Metz, Torri D. [14 ]
机构
[1] Ohio State Univ, Dept Obstet & Gynecol, Columbus, OH 43210 USA
[2] George Washington Univ, Biostat Ctr, Washington, DC USA
[3] Univ North Carolina Chapel Hill, Chapel Hill, NC USA
[4] Northwestern Univ, Chicago, IL USA
[5] Univ Texas Med Branch, Galveston, TX USA
[6] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA
[7] Univ Pittsburgh, Pittsburgh, PA USA
[8] Brown Univ, Providence, RI USA
[9] Univ Texas Hlth Sci Ctr Houston, Childrens Mem Hermann Hosp, Houston, TX USA
[10] Columbia Univ, New York, NY USA
[11] Case Western Reserve Univ, Cleveland, OH USA
[12] Univ Penn, Philadelphia, PA USA
[13] Univ Alabama Birmingham, Birmingham, AL USA
[14] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA
关键词
coronavirus; COVID-19; disease; infection; influenza; pregnancy; SARS-CoV-2; PREGNANT-WOMEN; MORTALITY;
D O I
10.1111/aji.13896
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundRecent data in nonpregnant individuals suggest a protective effect of influenza vaccination against SARS-CoV-2 infection and its severity.ObjectivesOur primary objective was to evaluate whether influenza vaccination was associated with COVID-19 severity and pregnancy and neonatal outcomes among those infected with SARS-CoV-2. The secondary objective was to examine the association between influenza vaccination and SARS-CoV-2 infection.Study DesignSecondary analysis of a multicenter retrospective cohort of pregnant people who tested positive for SARS-CoV-2 between March and August 2020, and a cohort of random deliveries during the same time period. The associations between 2019 influenza vaccination and the primary outcome of moderate-to-critical COVID-19 as well as maternal and perinatal outcomes were examined among all people who tested positive for SARS-CoV-2 between March and August 2020. The association between 2019 influenza vaccination and having a positive SARS-CoV-2 test was examined among a cohort of individuals who delivered on randomly selected dates between March and August 2020. Univariable and multivariable analyses were performed.ResultsOf 2325 people who tested positive for SARS-CoV-2, 1068 (45.9%) were vaccinated against influenza in 2019. Those who received the influenza vaccine were older, leaner, more likely to have private insurance, and identify as White or Hispanic. They were less likely to smoke tobacco and identify as Black. Overall, 419 (18.0%) had moderate, 193 (8.3%) severe, and 52 (2.2%) critical COVID-19. There was no association between influenza vaccination and moderate-to-critical COVID-19 (29.2% vs. 28.0%, adjusted OR 1.10, 95% CI 0.90-1.34) or adverse maternal and perinatal outcomes among those who tested positive. Of 8152 people who delivered in 2020, 4658 (57.1%) received the influenza vaccine. Prior vaccination was not associated with a difference in the odds of SARS-CoV-2 infection (3.8% vs. 4.2%, adjusted OR 0.94, 95% CI 0.74-1.19).ConclusionPrior influenza vaccination was not associated with decreased severity of COVID-19 or lower odds of SARS-CoV-2 infection in pregnancy.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] SARS-CoV-2 Infection and Vaccination Outcomes in Multiple Sclerosis
    Brunn, Jenna A.
    Dunietz, Galit Levi
    Romeo, Andrew R.
    Braley, Tiffany J.
    NEUROLOGY-CLINICAL PRACTICE, 2022, 12 (03) : E14 - E21
  • [42] SARS-CoV-2 infection, vaccination and acquired hemophilia: Reply
    Franchini, Massimo
    Focosi, Daniele
    THROMBOSIS RESEARCH, 2023, 230 : 152 - 152
  • [43] Pityriasis Lichenoides Following SARS-CoV-2 Infection/Vaccination
    Feschuk, Aileen M.
    Green, Maxwell
    Kashetsky, Nadia
    Maibach, Howard I.
    CURRENT DERMATOLOGY REPORTS, 2023, 12 (01) : 27 - 32
  • [44] Acquired immunity against SARS-CoV-2 infection and vaccination
    Renia, Laurent
    Ng, Lisa F. P.
    EMBO MOLECULAR MEDICINE, 2023, 15 (12)
  • [45] SARS-CoV-2 and Immunity: Natural Infection Compared with Vaccination
    Vespa, Simone
    Simeone, Pasquale
    Catitti, Giulia
    Buca, Davide
    De Bellis, Domenico
    Pierdomenico, Laura
    Pieragostino, Damiana
    Cicalini, Ilaria
    Del Boccio, Piero
    Natale, Luca
    Owens, Trevor
    Khorooshi, Reza
    De Laurenzi, Vincenzo
    Stuppia, Liborio
    Lanuti, Paola
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
  • [46] Effect of BCG Vaccination against SARS-CoV-2 Infection
    Li, Ya-Ping
    Cai, Jie-Wen
    Liao, Li-Juan
    Ding, Han
    Cao, Xun-Jie
    Zhu, Guo-Dong
    Guo, Xu-Guang
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2022, 75 (03) : 302 - 308
  • [47] Waning immunity to SARS-CoV-2 following vaccination or infection
    Hernandez-Suarez, Carlos
    Murillo-Zamora, Efren
    FRONTIERS IN MEDICINE, 2022, 9
  • [48] SARS-CoV-2 and influenza virus co-infection
    Cuadrado-Payan, Elena
    Montagud-Marrahi, Enrique
    Torres-Elorza, Manuel
    Bodro, Marta
    Blasco, Miquel
    Poch, Esteban
    Soriano, Alex
    Pineiro, Gaston J.
    LANCET, 2020, 395 (10236): : E84 - E84
  • [49] Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination
    Walmsley, Sharon
    Nabipoor, Majid
    Lovblom, Leif Erik
    Ravindran, Rizani
    Colwill, Karen
    Mcgeer, Alison
    Dayam, Roya Monica
    Manase, Dorin
    Gingras, Anne-Claude
    VACCINES, 2024, 12 (01)
  • [50] Booster Vaccination to Reduce SARS-CoV-2 Transmission and Infection
    Wald, Anna
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (04): : 327 - 328